Featured Research

from universities, journals, and other organizations

Don't 'Break The Waters' During Labor Without Good Clinical Reason, Concludes Cochrane Review

Date:
October 19, 2007
Source:
John Wiley & Sons, Inc.
Summary:
A Cochrane Review concluded that amniotomy, also known as breaking the waters, should not be used routinely as part of standard labour management and care. It found that it doesn't affect the woman's satisfaction with her childbirth experience, and doesn't result in the child being in better condition immediately after birth.

"We do not recommend that amniotomy, also known as breaking the waters, should be used routinely as part of standard labour management and care" says Cochrane Researcher Rebecca Smyth, after completing a systematic review of relevant research studies.

"Women should be informed that it doesn't shorten the first or second stage of labour, it doesn't affect the woman's satisfaction with her childbirth experience, and doesn't result in the child being in better condition immediately after birth."

This Cochrane Systematic Review found that breaking the waters may be associated with a slightly (non-significantly) higher rate of Caesarean section. Breaking the waters may cause changes in the baby's heart rate.

The aim of breaking the waters is to speed up and strengthen contractions, with the intention of shortening labour. The membranes are punctured using a long handled hook, and it is thought that hormones in the amniotic fluid that flows out will stimulate contractions. In some centres, it is performed as a routine part of care for all women in labour -- in others it is used only for women with a clinical need to have their waters broken.

Ms Smyth came to these conclusions after she and colleagues had identified 14 relevant studies that involved almost 5,000 women. The overall quality of the studies was variable, making it difficult for the group to give firm recommendations about the use of amniotomy. There is a need for further research in this area.

"Our evidence suggesting this lack of effect should be discussed with women in the antenatal period," says Smyth.


Story Source:

The above story is based on materials provided by John Wiley & Sons, Inc.. Note: Materials may be edited for content and length.


Cite This Page:

John Wiley & Sons, Inc.. "Don't 'Break The Waters' During Labor Without Good Clinical Reason, Concludes Cochrane Review." ScienceDaily. ScienceDaily, 19 October 2007. <www.sciencedaily.com/releases/2007/10/071016195950.htm>.
John Wiley & Sons, Inc.. (2007, October 19). Don't 'Break The Waters' During Labor Without Good Clinical Reason, Concludes Cochrane Review. ScienceDaily. Retrieved October 1, 2014 from www.sciencedaily.com/releases/2007/10/071016195950.htm
John Wiley & Sons, Inc.. "Don't 'Break The Waters' During Labor Without Good Clinical Reason, Concludes Cochrane Review." ScienceDaily. www.sciencedaily.com/releases/2007/10/071016195950.htm (accessed October 1, 2014).

Share This



More Health & Medicine News

Wednesday, October 1, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Some Positive Ebola News: Outbreak 'Contained' In Nigeria

Some Positive Ebola News: Outbreak 'Contained' In Nigeria

Newsy (Sep. 30, 2014) The CDC says a new case of Ebola has not been reported in Nigeria for more than 21 days, leading to hopes the outbreak might be nearing its end. Video provided by Newsy
Powered by NewsLook.com
UN Ebola Mission Head: Immediate Action Is Crucial

UN Ebola Mission Head: Immediate Action Is Crucial

AFP (Sep. 30, 2014) The newly appointed head of the United Nations Mission for Ebola Emergency Response (UNMEER), Anthony Banbury, outlines operations to tackle the virus. Duration: 00:39 Video provided by AFP
Powered by NewsLook.com
CDC Confirms First Case of Ebola in US

CDC Confirms First Case of Ebola in US

AP (Sep. 30, 2014) The CDC has confirmed the first diagnosed case of Ebola in the United States. The patient is being treated at a Dallas hospital after traveling earlier this month from Liberia. (Sept. 30) Video provided by AP
Powered by NewsLook.com
New Breast Cancer Drug Extends Lives In Clinical Trial

New Breast Cancer Drug Extends Lives In Clinical Trial

Newsy (Sep. 30, 2014) In a clinical trial, breast cancer patients lived an average of 15 months longer when they received new drug Perjeta along with Herceptin. Video provided by Newsy
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:

Strange & Offbeat Stories


Health & Medicine

Mind & Brain

Living & Well

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins